In 2017, more than 8 million packages of medicines were labeled in Russia to protect consumers from using substandard products. This was announced by Mikhail Mishustin, the head of the Russian Federal Tax Service.
“In 2017, to protect the public from substandard drugs and ensure the prompt withdrawal of substandard medicines from circulation, the agency implemented a drug labeling project, which is currently joined by about two thousand participants. More than 222 medicinal products have been registered, and more than 8 million packages have been labeled,” he said.
In February 2017, Russia started an experiment on drugs labeling to protect the life and health of consumers and safeguard the public from counterfeit drugs. The system allows to trace the drug on its way from the plant to the pharmacy. Each individual consumer package of drugs has its unique code containing data about the manufacturer and product, which is used by all market participants to enter information about the product movement along the supply chain into a unified information system
According to the Russian Minister of Health Veronika Skvortsova, the main objective for the second year of the experiment is to spread the labeling across all regions of Russia and connect all entities of drug circulation to the system. She said that the implementation of full-fledged drug labeling system could take on average five years.